glp-1 als Full article: Targeting metabolic dysfunction in amyotrophic lateral sclerosis: therapeutic potential of receptor agonists Glp-1 drugs offer brain benefits

Spiegelman, P

12D) and promoted lipid droplet formation (Fig

The Dulaglutide segment dominated the market with a share of 36.84% in 2025 due to its strong clinical efficacy, convenient once-weekly dosing schedule, proven cardiovascular benefits, and extensive physician adoption across diabetes treatment programs

Having worked with numerous runners dealing with stubborn Achilles problems, I consider BPC-157 one of the most exciting developments in sports rehabilitation

Chang et al., 2011

For people with eating disorders who are already restricting their food intake, this effect of GLP-1 medications could worsen behavior